Meena L P, Kumar K, Singh V K, Bharti Anju, Rahman S K H, Tripathi K
Assistant Professor, Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University , Varanasi, U.P., India .
J Clin Diagn Res. 2013 Jul;7(7):1394-6. doi: 10.7860/JCDR/2013/5456.3150. Epub 2013 Jul 1.
Knowledge on distribution of different mutations of thalassaemia, which are prevalent in a particular area, is a prerequisite for prenatal diagnosis.
Studying mutations in β - thalassaemia trait among blood donors in eastern Uttar Pradesh, India.
One thousand non - remunerated voluntary blood donors who were between 18 - 40 years of age, were included in the study. Both replacement and voluntary healthy blood donors were included. 4ml of venous blood was collected and it was stored at 4°C. Complete Blood Count (CBC), Haemoglobinopathy Screening and Molecular Analysis by ARMS - PCR (Amplification Refractory Mutation System - PCR) were done. Screening for β thalassaemia was done in a blood bank by using D - 10, Bio Rad, which was based on High Performance Liquid Chromatography (HPLC).
Twenty Eight subjects with β- thalassaemia trait were found among 1000 voluntary blood donors. IVS 1-5 (G-C) mutation was most common type (50%), followed by FS 8/9 (+G) 25% which was the second most common type. In our study, a rare mutation of CD 16 (-C) was also found. Out of 14 subjects who had IVS 1-5 (G-C) mutation (most common), six were from Varanasi (6/261) and five of them were Sindhis. It was seen that FS 41/42 (TCTT) mutation was distributed among all groups of populations which had higher prevalences of β-thalassaemia trait.
A comprehensive knowledge on beta thalassaemia mutations is necessary for determining a prenatal diagnosis. The occurrence of mutations may vary according to geographic region. Therefore, this study dealt with current problem of unknown mutations, in order to avoid complications.
了解特定地区常见的不同地中海贫血突变的分布情况是进行产前诊断的前提条件。
研究印度北方邦东部献血者中β地中海贫血特征的突变情况。
本研究纳入了1000名年龄在18至40岁之间的无偿献血者。包括替代献血者和自愿健康献血者。采集4ml静脉血并储存在4°C。进行了全血细胞计数(CBC)、血红蛋白病筛查以及通过ARMS-PCR(扩增阻滞突变系统-PCR)进行分子分析。在血库中使用基于高效液相色谱(HPLC)的Bio Rad D-10进行β地中海贫血筛查。
在1000名自愿献血者中发现了28名具有β地中海贫血特征的受试者。IVS 1-5(G-C)突变是最常见的类型(50%),其次是FS 8/9(+G),占25%,为第二常见类型。在我们的研究中,还发现了一种罕见的CD 16(-C)突变。在14名具有IVS 1-5(G-C)突变(最常见)的受试者中,有6名来自瓦拉纳西(6/261),其中5名是信德人。可以看出FS 41/42(TCTT)突变在所有β地中海贫血特征患病率较高的人群组中均有分布。
对于确定产前诊断,全面了解β地中海贫血突变是必要的。突变的发生可能因地理区域而异。因此,本研究处理了当前未知突变的问题,以避免并发症。